2Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light ehainamyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22April 2004. Am J Hematol, 2005, 79:319-328. 被引量：1
3Hess EP, White RD. Out-of-hospital cardiac arrest in patients with cardiac amylnidosis: presenting rhythms management and outcomes in four patients. Resuscitation, 2004, 60:105-111. 被引量：1
4Selvanayagam JB, Hawkins PN, Paul B, et al. Evaluation and management of the cardiae amyloidosis. J Am Coll Cardiol, 2007, 50: 2101-2110. 被引量：1
5Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: a comprehensive review. Arch Intern Med, 2006, 166:1805-1813. 被引量：1
6Kim SH, Kim SO, Han S, et al. Long-term comparison of apicalversus asymmetric hypertrophic cardiomyopathy. Int Heart J, 2013, 54: 207- 211. 被引量：1
7Hosoya Y, Watanabe M, Terashima M, et al. Cardiac magneticresonance imaging in a patient with amniotic fluid embolism associated with severe cardiopulmonary complications. Int Heart J, 2013, 54: 119-122. 被引量：1
8Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magneticresonanee in cardiac amyloidosis. Circulation , 2005, 111: 186-193. 被引量：1
9Niida T, Isoda K, Sasaki M, et al. Late gadolinium enhanced high resolution magnetic resonance imaging reveals pathophysiological condition of cardiac sarcoidosis. Int Heart J, 2009, 50: 263-266. 被引量：1
10Solar M, Zizka J, Dolezal J, et al. Contrast-enhanced magneticresonance and thallium scintigraphy in the detection of myocardial viability: a prospective comparative study. Int Heart J , 2006, 47: 521-532. 被引量：1
